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The nucleotide sequence of canine prostate arginine esterase mRNA was determined using a 400 bp cDNA clone and 
primer-extended cDNA transcripts for the 5’coding and noncoding regions. The mRNA contains 864 nucleotides encod- 
ing a protein of 236 amino acids preceded by 24 amino acids which constitutes both the signal and the zymogen peptides. 
The sequence indicates the presence of one potential glycosylation site. A high degree of homology was found between 
the canine enzyme and other members of the kallikrein family including human prostate specific antigen. The protein 
appears to be specified by a single gene. 
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1. INTRODUCTION 
Male reproductive tissues contain a variety of 
proteolytic enzymes [11. This is particularly evident 
in the dog in which more than 90% of the seminal 
plasma proteins are constituted by a proteolytic en- 
zyme, arginine esterase, derived from the prostate 
[2,3]. The human prostate and seminal plasma also 
contain a relatively abundant protease, prostate- 
specific antigen (PSA) [4]. This protein is better 
characterized than the canine enzyme. Its primary 
structure has recently been published independent- 
ly by 2 groups [5,6] who showed that it has exten- 
sive homology with several proteases of the 
kallikrein family. One of the presumed functions 
of this enzyme is to hydrolyze the high-molecular- 
mass seminal vesicle protein thus leading to the 
liquefaction of the seminal coagulum [7]. By con- 
Correspondence address: J .Y. Dub& Laboratory of Hormonal Plasmid pAgE400 containing an incomplete cDNA coding 
Bioregulation, Lava1 University Hospital Centre, 2705 Laurier for canine prostate arginine esterase was isolated and sequenced 
Boulevard, Sainte-Foy, Quebec GlV 4G2, Canada as in [ll]. 
The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession o. YOO751 
2.2. Oligonucleotide primers 
In order to determine the sequence of the 5’-portion of the 
trast, there is no seminal vesicle and no formation 
of a seminal coagulum in the canine species. The 
physiological substrate of arginine esterase is thus 
at present unknown, since the enzyme is unable to 
generate vasoactive kinins from kininogen [8] like 
the other members of the kallikrein family. This 
protein is highly dependent on androgenic hor- 
mones [9] and constitutes a valuable model system 
for the study of hormone action at the molecular 
level. A partial amino acid sequence of both the 
light and heavy chains of arginine esterase has been 
published by our laboratory [lo] and we have also 
recently described a 400 bp cDNA clone coding for 
this protein [ll]. Here, we propose the complete 
nucleotide sequence of its mRNA and the deduced 
amino acid sequence. 
2. MATERIALS AND METHODS 
2.1. Recombinant clone 
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mRNA not encoded in the cDNA clone pAgE400, we used the 
RNA sequencing and cDNA sequencing procedures of Geliebter 
et al. [12] based on the utilization of complementary 
oligonucleotide primers and primer extension. The whole se- 
quence strategy is illustrated in fig.1. The oligonucleotide 
primers were chemically synthesized using a Biosearch model 
‘8700 DNA synthesizer (New Brunswick Scientific). These 
primers were labeled with [y-32P]ATP (Amersham, 
5000 Ci/mmol) using T.I polynucleotide kinase (Bethesda 
Research Laboratories) as described by Geliebter et al. [12]. The 
first primer 5 ‘-CCCTGGGTG AAAAATCGJ ’ was com- 
plementary to the mRNA sequence from nucleotides 523 to 539 
in fig.2. With the first primer extension reaction, an additional 
200 nucleotides were read and thus a second oligonucleotide 
primer could be devised and so on. Table 1 lists all the primers 
that were synthesized for sequencing of both RNA and cDNA. 
2.3. RNA sequencing 
5 ng “P-labeled oligonucleotide primer and 2 pg poly(A)+ 
RNA prepared as described by Chirgwin et al. [13] were heated 
for 3 min at 80°C in 10~1 annealing buffer (250 mM 
KCl/lO mM Tris-HCl buffer, pH 8.3) and then for 45 min at 
a different temperature for each oligonucleotide according to 
the formula: T (“C) = 4(G+ C) + 2(A + 7) - 5. The mixture 
was then left standing at room temperature for 30 min. The 
reverse transcription reaction was performed as described [12] 
with the exception that 7-deaza-2 ’ -deoxyguanosine 5 ’ -triphos- 
phate from Pharmacia was substituted for dGTP. Furthermore, 
RAV-2 reverse transcriptase from Amersham was used with 
final concentrations of each ddNTP from Pharmacia (0.16 mM 
ddATP; 0.08 mM ddGTP, ddCTP and ddTTP). 
2.4. cDNA sequencing 
The annealing reaction was performed with 5 bg canine pros- 
tate poly(A)+ RNA in the presence of 25-50 ng of one 
Table 1 
Oligonucleotide primers for mRNA and cDNA sequencing 
Oligonucleotide primers (5 ’ -3 ‘) Corre- Annealing 
sponding tempera- 
position ture 
in mRNA (“C) 
sequence 
1 CCCTGGGTGAAAAATCG 539-523 47 
2TCTATCTTCCCCTGGACGGAT 383-363 59 
3CCTCACAATTACTGTTTGCAC 252-232 55 
4GCCTCCTATGATCCGGGGCTG 118-98 65 
5 CTCACTGTCTGCCAGCT l-17 49 
6TCTCAGCCCTGGCAGGTGGCT 138-158 55 
7 GAAGATGAAGGCCAGTTAGTC 285-305 57 
8GCTGTGAGGGTGATGGACCTG 435-455 63 
Primers 1-4 were complementary to the mRNA sequence and 
were used for mRNA sequencing while primers 5-8 were 
complementary to the cDNA sequence and were used for cDNA 
sequencing 
oligonucleotide primer (1, 2, 3 or 4) in a volume of 100 ~1. The 
reverse transcription reaction was then performed at 50°C for 
45 min with 150 ~1 reverse transcription buffer [12] containing 
35-40 U RAV-2 reverse transcriptase. The cDNA generated by 
primer extension was extracted sequentially with equal volumes 
of phenol, then phenol/chloroform (1: 1) and finally 
chloroform. The DNA dissolved in 0.4 M ammonium acetate 
was precipitated 3times with ethanol. The RNA: cDNA hybrids 
were denatured in boiling water for 5 min. Thereafter ‘*P- 
labeled oligonucleotide primers (5, 6, 7 or 8) were annealed to 
the cDNA and were extended with DNA polymerase I (Klenow 
fragment) from Amersham in the presence of dNTPs and 
clone 10 
4 
POIY (A) 
clone 5 
clone 10 
w 
v 
D-----, 
w 
-24 1 50 100 150 200 236 amino acids 
1 ’ 
I I I I I I 
I I I 1 I 1 200 400 600 800 864 nucleotides 
Fig. 1. Sequencing strategy for canine prostate arginine esterase mRNA. The horizontal rectangle shows the amino acid coding regions 
including the signal peptide (PRE) and putative activation peptide (PRO) while the lines extending from the rectangle represent he 
lengths of the 5’- and 3’noncoding regions. The horizontal arrows indicate the direction and extension of each sequencing run with 
clones 10 and 5 or by primer extension (wavy lines) with primers l-4 (mRNA sequencing) and primers 5-8 (cDNA sequencing). 
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ddNTPs [12]. The gels used for RNA and cDNA sequencing 
contained 5% acrylamide and 7 M urea. However, in some 
cases in which more details were needed in the vicinity of the 
primer, 10 and 15% polyacrylamide gels were also used. 
3. RESULTS 
3.1. Nucleotide sequence of arginine esterase 
mRNA 
2.5. Southern blot analysis 
Blood DNA was prepared as described by Gustafson et al. 
[14]. It was then completely digested with EcoRI, BarnHI, PstI, 
HindHI, HaeIII and KpnI. Samples containing 1Opg DNA 
were electrophoresed ingels of 1 Vo agarose [15] and transferred 
to Hybond-N membranes as suggested by the supplier (Amer- 
sham). After the transfer, the filters were prehybridized in 50% 
formamide hybridization buffer for 5 h at 42°C. The insert of 
the prostatic cDNA clone pAgE4OO [ll] was labeled with the 
multiprime labeling system of Amersham and hybridization was 
carried out at 42°C for 36 h in 6 x STE, 1 x Denhart’s solution, 
50% formamide, 0.1 Vo SDS and 100 fig/ml of salmon sperm 
DNA. The filters were washed 3 times with 1 x STE, 0.2% SDS 
at room temperature and then twice for 15 min at 68°C with 
1 x STE, 0.2% SDS. The filters were air-dried and exposed to 
Kodak X-AR2 X-ray films at - 80°C. 
The combination of seauencine of clone 
pAgE400 and of RNA and &cloned cDNA pro- 
vided all the information for obtaining the com- 
plete nucleotide sequence of arginine esterase 
mRNA (fig.2). The entire length of the mRNA ex- 
eluding the poly(A) tail comprises 864 nucleotides 
encoding a protein of 236 amino acids (M 26003) 
preceded by 24 amino acids constituting both the 
signal and zymogen peptides. The sequence also in- 
cludes 35 nucleotides in the 5 ‘noncoding region 
and 46 nucleotides in the 3 ’ -noncoding region 
after the UGA stop codon. The deduced amino 
acid sequence shows the presence of the catalytic 
-24 
CIJCAC”G~“GCCAGCIJC~AGCACU~G”CACC A% ;zG 65 
-10 -1 tl 
k-u 
“% C”G GGG U% ACU GGU GCU GM 0.X CAC UUC CAG g C% AtC ,:A GGA GGC AGG 
6’Y * 3Y 1 du pm hk phc 6ln dr dr =s 
I22 
IO 20 
6lY 6lu phr 
& ;:” $0 ,!% $ U. $G G U:G & G?G GU GtG ;:C 2” ,% GGU GM UUU 179 
30 40 
* cys 6lY 6lY “d h, .d .S” 9~=0 6l” “al ku thI his ala 
GC” UGU GGG GGU GUC CUG GUlJ MU CCA GAG LI:G GUG CUC ACA G% G:C CAC l% GCA 236 
50 al 
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70 60 
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I!$ A.. GCC GUC AUC CGU CCA GGG GM b:t /f& A% CAU dz CUC A% CUG CUG CM 407 
II0 
& Ju 6lu po 4. lys 5 6x Iys da val vat ku lY lY 
CUG GM GAG Ccc GCC MG MIA NX AM GCU GUG A% GUG A% bz CUG s AM MG 4& 
I20 I30 
GM CCU CCA UUG GGG AGU ACC UGC UAU GUC UCU GGA “:G GGC A$ KU 0:; C-3 GM 
6k PO PO h Jr = k Cyr W vd = 6lY 6’Y lk *OH 
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14 Is0 
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576 
I70 
CM UGU GCA AM G:A “TC A%, & 2 Gv;IG & % U% A$ C’tuo “?U G% G% G:C 635 
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dr 1~ PO 3n 
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220 2xl 
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Fig.2. Complete nucleotide sequence of canine prostatic arginine esterase mRNA and deduced amino acid sequence of the encoded 
preproenzyme. Amino acid numbering starts with the first residue of the mature enzyme [IO]. 
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triad (His 41, Asp 95, Ser 188) of serine protease 
and confirms that arginine esterase belongs to that 
class of enzymes. The amino acid sequence 
presents a high degree of homology with other 
kallikreins and in particular with human prostate 
specific antigen (58%), y-subunit of mouse nerve 
growth factor (56%) and human pancreatic 
kallikrein (55%). 
One particular feature of the nucleotide se- 
quence is the presence, 15 nucleotides upstream 
from the poly(A) stretch, of a putative 
polyadenylation signal consisting of AGUAAA as 
in human PSA [6], human pancreas kallikrein [la] 
and human prostatic secretory protein of 94 amino 
acids [17] but different from the more canonical 
AAUAAA. The amino acid sequence Asn-Leu-Ser 
Fig.3. Southern blot analysis of arginine esterase gene. Canine 
blood DNA was digested with EcoRI (l), BarnHI (2), PslI (3), 
Hind111 (4), Hue111 (5) and KpnI (6) and run on a 1% agarose 
gel. The DNA was transferred to Hybond-N membrane and 
hybridized with “P-labeled pAgE400 cDNA insert as described 
The total length of arginine esterase mRNA is 
quite similar to those of rat kallikrein mRNA [ 181, 
human pancreatic kallikrein mRNA [16], human 
cathepsin G [19] and rat pancreatic trypsinogens 
[20]. In contrast, human PSA mRNA is 
significantly longer (1.5 kb), particularly in its 
3 ‘-untranslated region [6]. In view of the high 
levels of conservation (90070) of the 3 ’ -untranslated 
region in the various rat kallikrein mRNAs, it has 
been suggested that this region could have impor- 
tant functions [18]. However, these observations 
cannot presently be interpreted as an indication 
that the 3 ‘-untranslated regions of human PSA 
and canine arginine esterase mRNAs have dif- 
ferent functions. 
in section 2. The amino acid sequence shows many 
190 
at positions 55-57 indicates the possibility of one 
N-linked glycosylation site. 
The amino acid sequence at positions l-26 and 
84-116 was found to be identical to the partial 
amino acid sequence of the NHZ-terminal portion 
of the heavy and light chains of native seminal 
plasma arginine esterase [lo]. 
3.2. Southern blot analysis 
In order to evaluate the number of arginine 
esterase-related genes in the dog genome, high- 
molecular-mass DNA from blood was digested 
with restriction enzymes and was analyzed by 
Southern blot analysis using the 400 bp cDNA 
clone as a probe (fig.3). A single strong hybridiza- 
tion band was observed after digestion of the DNA 
with HindIII, EcoRI, BarnHI or KpnI while 2 
bands were present after PstI digestion and 
HaeIII. 
4. DISCUSSION 
The present results are in complete agreement 
with our previous work on the partial amino acid 
sequence of arginine esterase from canine seminal 
plasma [lo]. Furthermore, they extend those we 
obtained with the partial cDNA clone pAgE400 
[l 11. They also illustrate the fact that the sequenc- 
ing of an abundant mRNA can be carried out ac- 
curately without cloning once a small portion of 
the nucleotide sequence is known or can be de- 
duced. An additional reason for the success of this 
approach is probably due to the absence of other 
closely related mRNAs in canine prostate. 
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similarities and also some differences between 
canine arginine esterase and other members of the 
kallikrein family. The prepropeptide sequence con- 
tains 24 amino acids like most of the other 
kallikreins. The boundary between the signal pep- 
tide and the zymogen peptide cannot be predicted 
with certainty. However, according to Von Heij- 
ne’s criteria [21], the probable cleavage site of the 
signal peptidase should be after the alanine at - 8. 
An additional possible prepeptide cleavage site has 
also been proposed after the glycine at - 12 for 
several kallikreins [ 181 on the basis of the struc- 
tural criteria elaborated by Perlman and Halvor- 
son [22]. The amino acid sequence of the arginine 
esterase prepropeptide is much less conserved than 
those of other kallikreins [18]. Another uncertain- 
ty is the exact extent of the autolysis loop. From 
the amino acid analysis previously reported [lo], 
native arginine esterase heavy chain begins with the 
alanine at position 84. By taking into consideration 
the amino acid composition of the native two- 
chain enzyme [lo] and this sequence, it can be 
calculated that the autolysis loop should involve 
11-13 amino acids. 
The potential glycosylation site at position 55 is 
in accord with previous results showing that only 
the light chain of arginine esterase was 
glycosylated [2,3]. This site is located at a different 
position from those observed in mouse, rat and 
human kallikreins. It is also different from the 
glycosylation site of human PSA at position 47 [a]. 
The amino acid sequence also provides useful in- 
formation on substrate specificity. The presence of 
an aspartate residue at position 182 indicates the 
trypsin-like specificity of the enzyme [23]. This 
result is in accord with the observed substrate 
specificity with synthetic substrates [8]. By con- 
trast, PSA has a serine at the equivalent position 
which is indicative of chymotrypsin-like specificity 
[6]. Also worthy of note is that Gly 205 and Ser 216 
are present at homologous positions in canine 
prostatic arginine esterase as well as in human pan- 
creatic kallikrein [16] and human PSA [6]. These 
amino acids are believed to allow access to the 
catalytic pocket of amino acid residues with bulky 
side chains [23]. Two other amino acids, Tyr 92 
and Trp 204, are presumed to be important deter- 
minants for the hydrolysis of plasma kininogen 
and release of vasoactive kinins [24]. In arginine 
esterase, Trp 204 is present but Tyr 92 has been 
replaced by an arginine residue. These results 
could thus explain the observed absence of 
kininogenase activity of canine arginine esterase 
tw51. 
The results obtained with the Southern blot 
analysis strongly suggest that a single gene of 
arginine esterase is present in the canine genome 
and that it is not part of a large kallikrein gene 
family such as that found in mouse [26] and rat 
[27]. In the genome of the mouse, the 24 kallikrein- 
related genes are highly homologous and are 
clustered on chromosome 7 [28]. In man, the 
kallikrein family may be smaller with a maximum 
of 3 members [29], respectively. The absence of 
genes highly homologous to canine prostate 
arginine esterase in Southern blot hybridization ex- 
periments does not exclude the possibility of a 
larger kallikrein family in that species or that all 
these genes could be clustered on a single gene 
locus. These questions will await the cloning of 
arginine esterase gene and of other kallikrein- 
related genes in the dog. 
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